Zhonghua Xue Ye Xue Za Zhi

The risk and management strategies for second primary tumor after CAR-T cell therapy

By R N Li, W Y Wang, F Yang, L L Zhang, J Shi

ReviewInterventions

The paper

R N Li, W Y Wang, F Yang, L L Zhang, J Shi

Institute of Hematology & Blood Diseases Hospital

Zhonghua Xue Ye Xue Za Zhi, 14 Aug 2026

doi.org/10.3760/cma.j.cn121090-20260118-00036 PubMed 42851188

Blood Advances4 Oct 2026
Electronic frailty index predicts CAR-T outcomes in older adults